TallyHQ
github
Client · LDA

THE CAMPAIGN FOR SUSTAINABLE RX PRICING

5 filings 30 bills mentioned 1 registrants 5 quarters ~$450,000 reported
Client ID
175642

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

S 1095
Stop STALLING Act
CPTPHA
5
S 1040
Drug Competition Enhancement Act
CPT
5
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
CPT
5
S 229
DTC Act of 2025
MMM
5
S 1097
Interagency Patent Coordination and Improvement Act of 2025
CPT
5
HR 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
PHA
5
S 43
Skinny Labels, Big Savings Act
CPT
5
S 1041
Affordable Prescriptions for Patients Act
CPT
5
HR 3269
ETHIC Act
CPT
4
HR 3789
DTC Act of 2025
MMM
4
S 1954
Biosimilar Red Tape Elimination Act
PHA
4
S 2276
ETHIC Act
CPT
4
HR 3152
Patent Eligibility Restoration Act of 2025
CPT
3
S 1546
Patent Eligibility Restoration Act of 2025
CPT
3
S 2630
Saving NSF’s Workforce Act
PHA
3
S 1032
Major Richard Star Act
PHA
3
S 1785
No Handouts for Drug Advertisements Act
CPTTAX
3
S 1533
A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contract physicians for disability examinations, and for other purposes.
CPT
3
HR 3160
PREVAIL Act
CPT
3
HR 3010
No Handouts for Drug Advertisements Act
CPTTAX
3
HR 1262
Mikaela Naylon Give Kids a Chance Act
PHA
2
S 1067
Concrete and Asphalt Innovation Act of 2025
PHA
2
S 2658
Medication Affordability and Patent Integrity Act
CPT
2
S 1302
Increasing Transparency in Generic Drug Applications Act
PHA
2
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
MMM
2
S 1414
Expedited Access to Biosimilars Act
PHA
1
S 3014
Ensuring Timely Access to Generics Act of 2025
PHA
1
HR 6485
Skinny Labels, Big Savings Act
CPT
1
HR 5526
Biosimilar Red Tape Elimination Act
PHA
1
HR 4570
Interagency Patent Coordination and Improvement Act of 2025
CPT
1

Registrants

Lobbying firms that filed on behalf of this client.

MEHLMAN CONSULTING, INC. 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.